America Should Launch a National Cancer Elimination Initiative for Massive Economic and Human Benefits
Source: https://www.facebook.com/americanspectator/. "Let’s Kill Cancer | The American Spectator | USA News and Politics." April 2, 2026. spectator.org
The Gist
The author argues America should make eliminating cancer a national priority, like we did with polio and COVID vaccines. He claims this would save millions of lives and generate huge economic benefits - up to $186 trillion - while requiring relatively modest investment costs.
Conclusion
The United States should launch a major national initiative to eliminate or drastically reduce cancer deaths, similar to past efforts for polio and COVID-19 vaccines
Premises
- Over 600,000 Americans die from cancer annually, with 25 million deaths worldwide
- Past four decades have shown stunning progress in cutting death rates of many cancers in half, proving progress is possible
- Eliminating cancer entirely would generate $186 trillion in total economic benefits over 35 years
- An 80% reduction in cancer deaths over 20 years would add $130 trillion in value to the U.S. economy
- The investment required (up to $800 billion in R&D costs) would yield a minimum 500% internal rate of return
- New developments in gene therapies, prevention strategies, and multi-cancer blood tests make elimination feasible
- Government deregulation of the drug approval process could accelerate bringing treatments to market
Assumptions
- Economic calculations accurately capture the true value of human life and reduced suffering
- Past success with polio and COVID-19 vaccines indicates similar success is achievable with cancer
- Private sector innovation combined with government deregulation will be sufficient to achieve these goals
- The projected timeline of achieving 80% reduction in 20 years is realistic
- Current technological developments will continue to advance at the projected pace